Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,998,776
+$275,603 QoQ
Shares Held
7,943
+0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
#1,958
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 56%
Shared 0%
None 44%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LCNB CORP holds $15,058,607 across 8 Drug Manufacturers - General names. ABBV ranks #5 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
26,283 | $3,377,365 | |
| 2 | JNJ |
Johnson & Johnson
|
12,559 | $3,189,609 | |
| 3 | AMGN |
Amgen Inc
|
6,635 | $2,402,666 | |
| 4 | LLY |
ELI LILLY & Co
|
1,804 | $2,163,771 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
7,943 | $1,998,776 | |
| 6 | NVS |
Novartis AG
|
8,673 | $1,359,232 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,990 | $287,523 | |
| 8 | PFE |
Pfizer Inc
|
11,614 | $279,665 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,998,776 | 7,943 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,723,173 | 7,923 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,698,137 | 7,432 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,732,382 | 7,482 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,388,808 | 7,482 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,567,628 | 7,482 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,297,032 | 7,299 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,433,902 | 7,261 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,245,406 | 7,261 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,322,228 | 7,261 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,127,096 | 7,273 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,076,213 | 7,220 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,040,115 | 7,720 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,202,446 | 7,545 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $1,279,951 | 7,920 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,048,180 | 7,810 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,196,179 | 7,810 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,173,838 | 7,241 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $846,114 | 6,249 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $654,986 | 6,072 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $683,950 | 6,072 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $657,111 | 6,072 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $645,257 | 6,022 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $534,036 | 6,097 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $618,926 | 6,304 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $486,092 | 6,380 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||